Tumor-derived CCL5 does not contribute to breast cancer progression.

Tumor-derived CCL5 does not contribute to breast cancer progression.

Item
http://www.wikidata.org/entity/Q40057931
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerTumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in FibroblastsA novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.CCL5 as an adjuvant for cancer immunotherapy.CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.CC chemokine receptor 5: the interface of host immunity and cancerThe potential to target CCL5/CCR5 in breast cancer.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
P2860

Tumor-derived CCL5 does not contribute to breast cancer progression.

Item
http://www.wikidata.org/entity/Q40057931
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
type
label
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
prefLabel
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P356
P1433
P1476
Tumor-derived CCL5 does not contribute to breast cancer progression.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698